Read More

Looking At Bristol-Myers Squibb’s Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Bristol-Myers Squibb (NYSE:BMY). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Read More

Analyzing Bristol-Myers Squibb’s Short Interest

Bristol-Myers Squibb's (NYSE:BMY) short percent of float has fallen 29.89% since its last report. The company recently reported that it has 27.33 million shares sold short, which is 1.29% of all regular shares that are available for trading.